Literature DB >> 23779257

β-Arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol.

Karl Björk1, Valeria Tronci, Annika Thorsell, Gianluigi Tanda, Natalie Hirth, Markus Heilig, Anita C Hansson, Wolfgang H Sommer.   

Abstract

RATIONALE: The rewarding effects of alcohol have been attributed to interactions between opioid and dopaminergic system within the mesolimbic reward pathway. We have previously shown that ablation of β-arrestin 2 (Arrb2), a crucial regulator of μ-opioid receptor function, attenuates alcohol-induced hyperlocomotion and c-fos activation in the nucleus accumbens.
OBJECTIVES: Here, we further investigated the role of Arrb2 in modulating alcohol-induced dopamine (DA) release and conditioned place preference (CPP). We also assessed the functional importance of Arrb2 for μ-opioid receptor surface expression and signaling following an acute alcohol challenge.
METHODS: Alcohol-evoked (0.375, 0.75, and 1.5 g/kg intraperitoneally) DA release was measured by in vivo microdialysis in the shell of nucleus accumbens. Reward was assessed by the CPP paradigm. Receptor function was assessed by μ-receptor binding and [(35)S]GTP-γ-S autoradiography.
RESULTS: In Arrb2 knockout mice accumbal DA levels reach maximum response at a lower dose compared to wild-type (wt) animals. In line with these results, Arrb2 knockout mice display increased CPP for alcohol as compared to wt mice. Finally, Arrb2 mutant mice display increased μ-opioid receptor signaling in the ventral and dorsal striatum and amygdala in response to a low dose of alcohol, indicating impaired desensitization mechanisms in these mice.
CONCLUSIONS: Our results show that Arrb2 modulates the response to low doses of alcohol on various levels including μ-opioid receptor signaling, DA release, and reward. They also reveal a clear dissociation between the effects of Arrb2 on psychomotor and reward behaviors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23779257      PMCID: PMC3817962          DOI: 10.1007/s00213-013-3166-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

1.  What and when to "want"? Amygdala-based focusing of incentive salience upon sugar and sex.

Authors:  Stephen V Mahler; Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2011-12-14       Impact factor: 4.530

Review 2.  Addiction.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Annu Rev Psychol       Date:  2002-06-10       Impact factor: 24.137

3.  Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.

Authors:  Elio Acquas; Gianluigi Tanda; Gaetano Di Chiara
Journal:  Neuropsychopharmacology       Date:  2002-08       Impact factor: 7.853

4.  R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.

Authors:  Claus J Loland; Maddalena Mereu; Oluyomi M Okunola; Jianjing Cao; Thomas E Prisinzano; Sonia Mazier; Theresa Kopajtic; Lei Shi; Jonathan L Katz; Gianluigi Tanda; Amy Hauck Newman
Journal:  Biol Psychiatry       Date:  2012-04-25       Impact factor: 13.382

5.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

6.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 7.  Signaling pathways mediating alcohol effects.

Authors:  Dorit Ron; Robert O Messing
Journal:  Curr Top Behav Neurosci       Date:  2013

8.  Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.

Authors:  Henry R Kranzler; Stephen Armeli; Jonathan Covault; Howard Tennen
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

9.  A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.

Authors:  David W Oslin; Wade Berrettini; Henry R Kranzler; Helen Pettinati; Joel Gelernter; Joseph R Volpicelli; Charles P O'Brien
Journal:  Neuropsychopharmacology       Date:  2003-06-18       Impact factor: 7.853

10.  Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Tatyana D Sotnikova; Ivan O Medvedev; Robert J Lefkowitz; Linda A Dykstra; Marc G Caron
Journal:  J Neurosci       Date:  2003-11-12       Impact factor: 6.167

View more
  9 in total

1.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

2.  The neurometabolic fingerprint of excessive alcohol drinking.

Authors:  Marcus W Meinhardt; Daniel C Sévin; Manuela L Klee; Sandra Dieter; Uwe Sauer; Wolfgang H Sommer
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

Review 3.  Arresting the Development of Addiction: The Role of β-Arrestin 2 in Drug Abuse.

Authors:  Kirsten A Porter-Stransky; David Weinshenker
Journal:  J Pharmacol Exp Ther       Date:  2017-03-16       Impact factor: 4.030

4.  Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.

Authors:  Derik Hermann; Natalie Hirth; Matthias Reimold; Anil Batra; Michael N Smolka; Sabine Hoffmann; Falk Kiefer; Hamid R Noori; Wolfgang H Sommer; Gerald Reischl; Christian la Fougère; Karl Mann; Rainer Spanagel; Anita C Hansson
Journal:  Neuropsychopharmacology       Date:  2016-08-11       Impact factor: 7.853

Review 5.  Behavioral, Neural, and Molecular Mechanisms of Conditioned Mate Preference: The Role of Opioids and First Experiences of Sexual Reward.

Authors:  Gonzalo R Quintana; Conall E Mac Cionnaith; James G Pfaus
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

6.  Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease.

Authors:  Hindol Rakshit; Nitin Rathi; Debjani Roy
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

7.  Brain Lateralization in Mice Is Associated with Zinc Signaling and Altered in Prenatal Zinc Deficient Mice That Display Features of Autism Spectrum Disorder.

Authors:  Stefanie Grabrucker; Jasmin C Haderspeck; Ann Katrin Sauer; Nadine Kittelberger; Harun Asoglu; Alireza Abaei; Volker Rasche; Michael Schön; Tobias M Boeckers; Andreas M Grabrucker
Journal:  Front Mol Neurosci       Date:  2018-01-15       Impact factor: 5.639

8.  Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function.

Authors:  Nitish Mittal; Ani Minasyan; Nicole Romaneschi; Joshua K Hakimian; Gabriel Gonzalez-Fernandez; Ralph Albert; Nina Desai; Ian A Mendez; Timothy Schallert; Sean B Ostlund; Wendy Walwyn
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

9.  Nicotine increases alcohol self-administration in male rats via a μ-opioid mechanism within the mesolimbic pathway.

Authors:  Esi Domi; Li Xu; Marvin Pätz; Anton Nordeman; Gaëlle Augier; Lovisa Holm; Sanne Toivainen; Eric Augier; Anita C Hansson; Markus Heilig
Journal:  Br J Pharmacol       Date:  2020-08-14       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.